These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 16904109

  • 1. Identification of the HIV-1 gp41 core-binding motif--HXXNPF.
    Huang JH, Liu ZQ, Liu S, Jiang S, Chen YH.
    FEBS Lett; 2006 Sep 04; 580(20):4807-14. PubMed ID: 16904109
    [Abstract] [Full Text] [Related]

  • 2. The mechanism by which molecules containing the HIV gp41 core-binding motif HXXNPF inhibit HIV-1 envelope glycoprotein-mediated syncytium formation.
    Huang JH, Yang HW, Liu S, Li J, Jiang S, Chen YH.
    Biochem J; 2007 May 01; 403(3):565-71. PubMed ID: 17223796
    [Abstract] [Full Text] [Related]

  • 3. Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope.
    Menendez A, Chow KC, Pan OC, Scott JK.
    J Mol Biol; 2004 Apr 23; 338(2):311-27. PubMed ID: 15066434
    [Abstract] [Full Text] [Related]

  • 4. Identification of critical antibody-binding sites in the HIV-1 gp41 six-helix bundle core as potential targets for HIV-1 fusion inhibitors.
    Li J, Chen X, Huang J, Jiang S, Chen YH.
    Immunobiology; 2009 Apr 23; 214(1):51-60. PubMed ID: 19159827
    [Abstract] [Full Text] [Related]

  • 5. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
    Gallo SA, Sackett K, Rawat SS, Shai Y, Blumenthal R.
    J Mol Biol; 2004 Jun 25; 340(1):9-14. PubMed ID: 15184018
    [Abstract] [Full Text] [Related]

  • 6. The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation.
    Dwyer JJ, Hasan A, Wilson KL, White JM, Matthews TJ, Delmedico MK.
    Biochemistry; 2003 May 06; 42(17):4945-53. PubMed ID: 12718536
    [Abstract] [Full Text] [Related]

  • 7. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
    Julien JP, Bryson S, Nieva JL, Pai EF.
    J Mol Biol; 2008 Dec 12; 384(2):377-92. PubMed ID: 18824005
    [Abstract] [Full Text] [Related]

  • 8. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
    Korazim O, Sackett K, Shai Y.
    J Mol Biol; 2006 Dec 15; 364(5):1103-17. PubMed ID: 17045292
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
    Pritsker M, Rucker J, Hoffman TL, Doms RW, Shai Y.
    Biochemistry; 1999 Aug 31; 38(35):11359-71. PubMed ID: 10471286
    [Abstract] [Full Text] [Related]

  • 11. A recombinant mimetics of the HIV-1 gp41 prehairpin fusion intermediate fused with human IgG Fc fragment elicits neutralizing antibody response in the vaccinated mice.
    Qi Z, Pan C, Lu H, Shui Y, Li L, Li X, Xu X, Liu S, Jiang S.
    Biochem Biophys Res Commun; 2010 Jul 30; 398(3):506-12. PubMed ID: 20599765
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rapid and automated fluorescence-linked immunosorbent assay for high-throughput screening of HIV-1 fusion inhibitors targeting gp41.
    Liu S, Boyer-Chatenet L, Lu H, Jiang S.
    J Biomol Screen; 2003 Dec 30; 8(6):685-93. PubMed ID: 14711394
    [Abstract] [Full Text] [Related]

  • 14. Two interaction modes of the gp41-derived peptides with gp41 and their correlation with antimembrane fusion activity.
    Ryu JR, Jin BS, Suh MJ, Yoo YS, Yoon SH, Woo ER, Yu YG.
    Biochem Biophys Res Commun; 1999 Nov 30; 265(3):625-9. PubMed ID: 10600471
    [Abstract] [Full Text] [Related]

  • 15. Development of a FRET assay for monitoring of HIV gp41 core disruption.
    Xu Y, Hixon MS, Dawson PE, Janda KD.
    J Org Chem; 2007 Aug 31; 72(18):6700-7. PubMed ID: 17685571
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of a critical motif for the human immunodeficiency virus type 1 (HIV-1) gp41 core structure: implications for designing novel anti-HIV fusion inhibitors.
    He Y, Cheng J, Li J, Qi Z, Lu H, Dong M, Jiang S, Dai Q.
    J Virol; 2008 Jul 31; 82(13):6349-58. PubMed ID: 18417584
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
    Gustchina E, Hummer G, Bewley CA, Clore GM.
    J Med Chem; 2005 Apr 21; 48(8):3036-44. PubMed ID: 15828842
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.